Powder Delivery TRIZ Cases

A self-emulsifying DIM carrier uses HLB-balanced surfactants to stop aqueous crystallization and improve oral bioavailability.

Controlled osmotic pressure, pH, and excipients improve aerosol dose stability and particle distribution for inhaled adenovirus vaccination.

SA-FasL-modified PLG scaffolds curb early inflammatory cell infiltration, improving stem cell-derived beta-cell engraftment and differentiation.

A four-part herbal composition targets blood replenishment, water excretion, and toxin removal to improve skin, hair, and nail symptoms.

A PEG shell and hydrophobic polymer core improve nanoparticle stability, payload versatility, and controlled release in aqueous delivery.

An acidic co-solvent formulation keeps carfilzomib soluble and stable without cyclodextrins, easing injectable preparation and use.

PEG-coated gold nanoparticles improve brain delivery for Huntington's therapy while limiting liver clearance, toxicity, and neuroinflammation.

Metal-chelated polyphenol carriers replace cationic lipids to deliver nucleic acids with lower toxicity, reduced immunogenicity, and better stability.

A recombinant alpha-1-antitrypsin dry powder uses di-leucine and tri-leucine to improve stability, lung delivery, and patient compliance.

A chimeric Factor VIII-VWF formulation uses stabilizing excipients to extend half-life and sustain activity in hemophilia A treatment.

High-Z nanoparticles and XRF feedback let radiotherapy refocus dose on the tumor while limiting radiation damage to healthy tissue.

Inorganic carriers help orally delivered probiotics form gut biofilms, extend colonization, rebuild microbiota, and support tumor therapy.

Controlled heating of a freeze-dried microvesicle product improves pressure resistance and bloodstream persistence after reconstitution.

D-amino-acid NPY analogs delivered intranasally improve Y1 receptor targeting and reduce PTSD-related anxiety and depression.

Cyclodextrin encapsulation and lyophilization keep insulin soluble in preterm infant feeds, supporting intestinal maturation and fewer severe gut complications.

A solid triglyceride powder adsorbed on a carrier delays gastric release, reduces diarrhea, and improves absorption for higher-dose therapy.

Mineral-coated microparticles adsorb active agents for localized sustained release, preserving protein activity and reducing injection frequency.

Non-toxic alkyl glycosides improve peptide and protein absorption and stability for oral and mucosal delivery without irritation.

A pH 5.4 liquid anti-TIGIT antibody formulation uses histidine, amino acids, sucrose, and polysorbate 80 to preserve stability from 5°C to 25°C.

Core-shell nanodiamond and zinc oxide particles improve skin healing, collagen production, and topical active delivery while adding UV protection.

Particle-bound targeting compounds direct nucleic acid payloads to T cells, improving genetic modification while limiting off-target cell effects.

pH-responsive polyglycerol-conjugated lipids help LNPs deliver large nucleic acids while reducing immune activation and delivery barriers.

Microporous zirconium silicate boosts potassium exchange in the GI tract while limiting inflammation, urine pH increase, and particle entry.

Iodinated acrylamide copolymers make polyacrylamide hydrogel implants visible under x-ray while preserving permanent tissue bulking.

Pathological shear triggers aptamer shape change to release TPA at thrombi, improving clot dissolution while limiting systemic bleeding.

An Actinium-225 resin microsphere recaptures decay daughters and pairs alpha therapy with Zirconium-89 PET dosimetry to limit liver damage.

A sugar-amino acid formulation stabilizes anti-α4β7 antibodies by limiting deamidation, oxidation, and aggregation during treatment.

IEDDA click chemistry rapidly attaches aptamers or antibodies to PBAE nanoparticles, improving target-specific gene delivery without complex synthesis.

Gelsolin modulates actin dynamics to reduce lung inflammation, prevent hypoalveolarization, and slow bronchopulmonary dysplasia progression.

Albumin nanoparticle conjugates use chelation and the EPR effect to improve PET and SPECT tumor imaging accuracy with less invasive diagnosis.

Self-assembling nanovesicles improve insoluble IDO inhibitor delivery and co-carry ICD inducers to boost tumor immune response.

Freeze-dried arsenic trioxide enables oral dosing with IV-comparable bioavailability and over three months of shelf stability.

Buffer, stabilizer, and antioxidant selection keeps anti-PD-1 antibodies stable at high concentration while limiting oxidation, aggregation, and injection difficulty.

Controlled tobacco heating enriches key aroma volatiles in dry powder particles, improving smoking-like inhalation with less harsh mouth delivery.

Buffer, stabilizer, and antioxidant choices keep anti-PD-1 antibodies stable at high concentration while limiting viscosity and oxidation.

Dual-sized hydrogel particles sustain antigen and IL-10 delivery to dendritic cells, promoting long-term immune tolerance in T1D.

A VLDL carrier with a VLDLR-binding ligand improves tumor uptake of anticancer drugs while reducing off-target effects on healthy tissues.

Ceramic bio-absorbable particles localize and slowly release antibiotics, treating bone infections while reducing systemic side effects.

Near-infrared fluorescent quantum dots enable precise skeletal tracking in freely moving animals without X-ray radiation or fur interference.

Curved inlet channels and dual recesses reduce powder migration and airflow disruption, helping a preloaded inhaler empty the capsule fully.

Replacing bromide with tosylate in glycopyrrolate salts helps treat hyperhidrosis while reducing skin irritation and bromism risk.

Mini-tablet and granule CFTR formulations improve pediatric administration by preserving dosing accuracy, absorption, and flexibility.

Anhydrous mesoporous magnesium carbonate stabilizes amorphous APIs, improving solubility, storage stability, and dose loading in oral formulations.

Cooling a consolidated fabric before adding the active binder reduces volatilization and places flavor at the surface for faster saliva release.

A freeze-dried fruit-oil psychedelic bite melts in the mouth to deliver a tamper-resistant single dose with easier use and preserved potency.

Pulmonary delivery of verteporfin-based formulations raises lung drug concentration to reduce viral load while limiting systemic side effects.

Block copolymer nanoparticles use self-assembly and nucleic acid complexation to carry large gene-editing payloads with better stability and transfection.

A thermogelling polymer and alginate microparticles form a semi-interpenetrating depot that limits burst release of high-concentration antibodies.

Block copolymer nanoparticles carry larger nucleic acid payloads in vivo while avoiding immune responses and enabling sustained antibody expression.

Defined MSC marker thresholds and controlled expansion produce homogeneous, cryopreservable cell doses with more consistent therapeutic effects.